Pierre-Henri Benhamou
Direktor/Vorstandsmitglied bei France Biotech Association
Ursprung des Netzwerks ersten Grades von Pierre-Henri Benhamou
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 39 | |
France Biotech Association
 France Biotech Association Miscellaneous Commercial ServicesCommercial Services France Biotech Association is an independent association founded in 1997 that brings together healthtech entrepreneurs and their expert partners. The non-profit company is based in Paris, France. The association actively contributes to meeting the many challenges of the healthtech industry, such as companies' financing, innovation-related taxes, regulatory and market access related issues. It offers concrete competition and solutions through its commissions and working groups to help startups and SMEs become international leaders capable of rapidly developing and bringing innovative solutions to patients. The French company was founded by Philippe Pouletty, Pascal Brandys, Denis J. Lucquin.
34
| Non-Profit Organization | Miscellaneous Commercial Services | 34 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Pierre-Henri Benhamou
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Shire ViroPharma, Inc.
 Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | Pharmaceuticals: Major | Chief Executive Officer Chief Operating Officer | |
| SANOFI | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
| IPSEN | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal Director of Finance/CFO Comptroller/Controller/Auditor Corporate Officer/Principal | |
| NTG NORDIC TRANSPORT GROUP A/S | Trucking | Director/Board Member Chief Executive Officer Corporate Officer/Principal | |
| GUERBET | Medical Specialties | General Counsel Sales & Marketing | |
| Imperial College London | College/University | Graduate Degree Graduate Degree | |
Institut Pasteur
 Institut Pasteur Investment Trusts/Mutual FundsMiscellaneous The Institut Pasteur is a private non-profit foundation which contributes to the prevention and treatment of disease, through research, education, and public health activities. The firm was founded in 1887, and is based in Paris. | Investment Trusts/Mutual Funds | Director/Board Member Corporate Officer/Principal | |
Ipsen International GmbH
 Ipsen International GmbH Industrial MachineryProducer Manufacturing Ipsen International GmbH manufactures and distributes furnaces and plant systems. Its products include sealed quench furnaces; chamber and multi-purpose chamber furnaces; horizontal and vertical furnaces; EcoFire system; HydroNit Sensor; HybridCarb; and EndoSave system. The firm also provides software processes such as Carb-o-Prof 4.0, AutoMag, Vacu-Prof, and Conti-Control. The company was founded by Harold Ipsen in 1957 and is headquartered in Kleve, Germany. | Industrial Machinery | Corporate Officer/Principal Public Communications Contact | |
| ALK-ABELLÓ A/S | Biotechnology | Chief Tech/Sci/R&D Officer Director of Finance/CFO Chief Executive Officer | |
Sofinnova Partners SAS
 Sofinnova Partners SAS Investment ManagersFinance Sofinnova Partners SA (Sofinnova) is an independent venture capital firm established in 1972 and headquartered in Paris, France. Originally known as Sofinnova, the first venture capital firm created in France, the firm created a U.S. subsidiary in San Francisco in 1976. In 1997, both firms were bought out by their management teams, which become the majority shareholders of the new companies, Sofinnova Partners in Paris and Sofinnova Ventures in San Francisco. | Investment Managers | Investment Committee Member Private Equity Investor | |
| VALERIO THERAPEUTICS | Pharmaceuticals: Major | Founder Chief Executive Officer | |
| Copenhagen Business School | College/University | Graduate Degree Graduate Degree | |
| CELLECTIS S.A. | Pharmaceuticals: Major | Founder Director of Finance/CFO Chairman | |
| THERADIAG | Medical Specialties | Chairman Chief Executive Officer | |
Trophos SA
 Trophos SA Pharmaceuticals: MajorHealth Technology Trophos SA engages in manufacturing and development of pharmaceutical products. It offers medicines to patients with conditions such as amyotrophic lateral sclerosis, spinal muscular atrophy and cardiac ischemia reperfusion injury. The company was founded by Antoine Beret and Michel Delaage in 1991 and is headquartered in Marseille, France. | Pharmaceuticals: Major | Chief Executive Officer Chief Executive Officer | |
| Université Paris 1 Panthéon-Sorbonne | College/University | Doctorate Degree Doctorate Degree | |
| Université Paris Dauphine-PSL | College/University | Graduate Degree Graduate Degree | |
| Ecole Polytechnique | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| École des Hautes Études Commerciales de Paris | College/University | Masters Business Admin Undergraduate Degree Undergraduate Degree Graduate Degree | |
| École Nationale Supérieure des Mines de Paris | College/University | Undergraduate Degree Graduate Degree | |
| Institut National Agronomique Paris-Grignon | College/University | Graduate Degree Graduate Degree Undergraduate Degree | |
Sophion Bioscience A/S
 Sophion Bioscience A/S Medical SpecialtiesHealth Technology Sophion Bioscience A/S develops, manufactures and markets instruments and supplies automated patch clamping. It develops throughput patch clamp solutions for functional characterization of living cells. The firm products are used in pharmaceutical and biotech companies around the world. The company was founded in July 2007 and is headquartered in Ballerup, Denmark. | Medical Specialties | Chairman Chairman | |
BPIFrance Investissement SAS
 BPIFrance Investissement SAS Investment ManagersFinance BPIFrance Investissement SAS (BPIfrance Investissement) is the private equity arm and subsidiary of State-owned Banque Publique d'Investissement in France. Formerly known as CDC Entreprises SAS, the firm was established in 1994 to carry out public-interest missions such as employment creation and momentum initiation in the private equity field. In 2013 they became BPIfrance Investissement when CDC Entreprises, FSI and FSI Régions merged. Headquartered in Paris, BPIfrance Investissement invests of behalf of the Government of France, as well as for third parties including FEI-Fonds Européen d'Investissement, BEI-Banque Européenne d'Investissement and BPCE SA. The firm invests directly or indirectly in SMEs and intermediate-sized companies at all stages of their development. | Investment Managers | Private Equity Analyst Private Equity Investor | |
Takara Bio Europe AB
 Takara Bio Europe AB Miscellaneous Commercial ServicesCommercial Services Takara Bio Europe AB is a provider of stem cell derived products and technologies which will drive unprecedented innovation in drug discovery and regenerative medicine today and in the future. The company was first in the world to bring to the market human embryonic stem (hES) cell-derived hepatocytes and cardiomyocytes for use as drug discovery tools. Cellartis is also the single commercial source of ethically derived hES cell lines and has developed cell lines for a range of uses. This hES cell technology platform offers a path to tools and regenerative medicine discoveries of the future. The company was founded in 2001 and is headquartered in Gothenburg, Sweden. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
CYTOO SA
 CYTOO SA Medical SpecialtiesHealth Technology CYTOO SA operates as a contract research organization which develops physiological cell-based assays. It focuses on developing, manufacturing, and commercializing new technologies for cell analysis for life sciences research community. The company has offices in Bethesda and Grenoble. The company was founded by François Chatelain, Alexandra Fuchs and Jacques Lewiner in 2008 and is headquartered in Grenoble, France. | Medical Specialties | Director/Board Member Director/Board Member | |
Hemarina SA
 Hemarina SA BiotechnologyHealth Technology Hemarina SA operates as a biotechnology company which develops oxygen carrier for therapeutic and industrial applications. It offers organ preservation, wound healing, hemoglobin oxygen-carrier, cell culture and bioproduction and other perspective products. The company was founded by Franck Zal, Elisabeth Leize, Morgane Rousselot and Laurent Meijer on March 26, 2007 and is headquartered in Morlaix, France. | Biotechnology | Chairman Chief Executive Officer | |
Ipsen Pharma SAS
 Ipsen Pharma SAS Pharmaceuticals: MajorHealth Technology Ipsen Pharma SAS is a biopharmaceutical company that develops medicines in oncology, neuroscience and rare diseases. The company was founded by Henri Beaufour in 1929 and is headquartered in Boulogne-Billancourt, France. | Pharmaceuticals: Major | President Director of Finance/CFO | |
| SENSORION | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Atlanpole Biotherapies
 Atlanpole Biotherapies Miscellaneous Commercial ServicesCommercial Services Atlanpole Biotherapies provides immunotherapy, regenerative medicine, and radio pharmacy bio cluster services. The company is based in Nantes, France. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
| PIXIUM VISION | Medical Specialties | Director/Board Member Director/Board Member | |
| GENSIGHT BIOLOGICS S.A. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director of Finance/CFO | |
MedDay Pharmaceuticals SAS
 MedDay Pharmaceuticals SAS BiotechnologyHealth Technology MedDay Pharmaceuticals SAS operates as a biotechnology company developing new drugs for nervous system disorders. The firm operates for the treatment of neuro-metabolic diseases. The company was founded by Frédéric Sedel and Guillaume Brion in 2011 and is headquartered in Paris, France. | Biotechnology | Director/Board Member Director/Board Member | |
| LYSOGENE | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member Director of Finance/CFO | |
ENYO Pharma SA
 ENYO Pharma SA BiotechnologyHealth Technology ENYO Pharma SA operates as a biopharmaceutical company. The firm's research and development is focused on human infecting viruses, with the first two programs being dedicated to the treatment of severe and seasonal flu and chronic hepatitis B. The company was founded by Jacky Vonderscher, Jean-Jacques Garaud, Benoît de Chassey, Laurène Meyniel-Schicklin, Patrice André and Vincent Lotteau January 2014 and is headquartered in Lyon, France. | Biotechnology | Director/Board Member Director/Board Member | |
| OSE IMMUNOTHERAPEUTICS | Pharmaceuticals: Major | Chairman Director/Board Member | |
| CORETECH 5 | Agricultural Commodities/Milling | Director/Board Member Director/Board Member | |
| BETTER COLLECTIVE A/S | Miscellaneous Commercial Services | Director of Finance/CFO Chairman | |
One Biosciences SAS
 One Biosciences SAS BiotechnologyHealth Technology One Biosciences SAS engages in single-cell technology research and development activities. It aims to identify new therapeutics for difficult-to-treat diseases. The company was founded by Céline Vallot, Magali Richard, and David Schilansky and is headquartered in Paris, France. | Biotechnology | Founder Founder | |
Olgram SAS
 Olgram SAS Miscellaneous Commercial ServicesCommercial Services Olgram SAS provides scientific research and development services. The company is based in Brehan, France. The French company was founded by Hervé Balusson, Maryvonne Hiance, Karim Asehnoune, Pi Nyvall Collén, Pierre Rocheteau. Pierre Rocheteau has been the CEO since incorporation. | Miscellaneous Commercial Services | Founder Founder | |
Home Biosciences SAS
 Home Biosciences SAS BiotechnologyHealth Technology Home Biosciences SAS is a biotech venture builder that partners with academics and scientists to develop life-changing therapies for patients. The company is based in France and has subsidiaries in the country. The French company's operating model allows its teams to focus on scientific and operational excellence to expedite and de-risk the discovery and development paths of its projects, which are housed in dedicated ventures and fully financed by Home Biosciences. Home Biosciences was founded in 2019 by Magali Richard and David S. Schilansky, who has been the CEO since its inception. | Biotechnology | Chief Executive Officer Founder | |
| Healthtech For Care | Corporate Officer/Principal Chairman | ||
Orphan Europe SARL
 Orphan Europe SARL Pharmaceuticals: MajorHealth Technology Orphan Europe SARL develops and distributes orphan drugs for the treatment of rare diseases. The firm's products include Normosang, Cystagon, Pedea, Carbaglu, Wilzin, Cystadane. The company was founded by William Gunnarsson in 1990 and is headquartered in Puteaux, France. | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel |
Statistik
International
| Frankreich | 41 |
| Dänemark | 6 |
| Vereinigte Staaten | 3 |
| Vereinigtes Königreich | 2 |
| Deutschland | 2 |
Sektoral
| Health Technology | 27 |
| Consumer Services | 13 |
| Commercial Services | 6 |
| Finance | 3 |
| Transportation | 2 |
Operativ
| Director/Board Member | 365 |
| Corporate Officer/Principal | 116 |
| Chairman | 111 |
| Chief Executive Officer | 75 |
| Independent Dir/Board Member | 70 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Peter Hutt | 69 |
| Mette Agger | 30 |
| Michel de Rosen | 28 |
| Franck Lescure | 28 |
| Torbjørn Bjerke | 27 |
| Chahra Khaoua Epouse Louafi | 26 |
| Flemming Heise Pedersen | 24 |
| Didier Hoch | 24 |
| Rafaèle Elisabeth Tordjman | 23 |
| Franck Grimaud | 22 |
| Damian Marron | 21 |
| Maïlys Ferrère | 21 |
| Jens Bager | 18 |
| Claire Giraut | 17 |
| Daniel Tassé | 16 |
- Börse
- Insiders
- Pierre-Henri Benhamou
- Unternehmensverbindungen
